Not available
Quote | Theravance Biopharma Inc. (NASDAQ:TBPH)
Last: | $9.13 |
---|---|
Change Percent: | -0.76% |
Open: | $9.13 |
Close: | $9.20 |
High: | $9.13 |
Low: | $9.13 |
Volume: | 22,728 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
News | Theravance Biopharma Inc. (NASDAQ:TBPH)
2024-04-15 14:19:53 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips The stock market may have pulled back a bit from the all-time high reached late last month but the S&P 500 remains 7.4% higher in 2024. Technology stocks continue to be top performe...
2024-04-12 10:00:50 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Drug...
Message Board Posts | Theravance Biopharma Inc. (NASDAQ:TBPH)
Subject | By | Source | When |
---|---|---|---|
On the move back up. Smart money | ok2buy | investorshub | 09/02/2021 2:42:13 PM |
May have bought a little too early, but | ok2buy | investorshub | 08/28/2021 1:47:56 PM |
Put my money where my mouth is, filled | ok2buy | investorshub | 08/24/2021 3:26:24 PM |
Missed their end point in the Phase IIB | ok2buy | investorshub | 08/24/2021 2:52:42 PM |
whytestocks: $TBPH bears and bulls | whytestocks | investorshangout | 11/17/2019 2:25:47 PM |
News, Short Squeeze, Breakout and More Instantly...
Theravance Biopharma Inc. Company Name:
TBPH Stock Symbol:
NASDAQ Market:
2024-04-12 08:00:07 ET Julian Harrison from BTIG issued a price target of $21.00 for TBPH on 2024-04-12 06:36:00. The adjusted price target was set to $21.00. At the time of the announcement, TBPH was trading at $8.93. The overall price target consensus is at $14.00 with...
Theravance Biopharma, Inc. to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine's Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (nOH) in Patients with Multiple System Atrophy (MSA) on May 23, 2024 PR Newswire DUBLIN , ...